कृपया अन्य खोज का प्रयास करें
Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which is in Phase I clinical trial and used to replace the use of bowel tissue in bladder cancer patients requiring a non-continent urinary diversion after bladder removal surgery. The company has a license agreement with Children’s Medical Center Corporation (CMCC) for the license of certain patent rights and intellectual property rights owned or controlled by CMCC related to tissue engineering technology. Tengion, Inc. was founded in 2003 and is headquartered in Winston-Salem, North Carolina. On December 29, 2014, Tengion, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Alan B. Retik | - | - | Member of Research & Development Advisory Board |
Buddy D. Ratner | - | - | Member of Research & Development Advisory Board |
Nancy Bachrach | - | 2012 | Member of Business Advisory Board |
Victor J. Dzau | 75 | - | Member of Research & Development Advisory Board |
Alan J. Russell | - | - | Member of Scientific Advisory Board |
Richard J. Zeckhauser | 80 | - | Member of Business Advisory Board |
Arthur Leonard Caplan | - | - | Member of Research & Development Advisory Board |
Robert Nerem | - | - | Member of Research & Development Advisory Board |
William D. Schwieterman | 63 | - | Member of Research & Development Advisory Board |
Mark P. Schoenberg | 63 | - | Member of Scientific Advisory Board |
Prediman K. Shah | - | - | Member of Scientific Advisory Board |
Geeta S. Vemuri | - | - | Board Observer |
John L. Miclot | 62 | 2011 | Director |
Richard E. Kuntz | 64 | 2010 | Director |
Stephen F. Badylak | - | - | Member of Research & Development Advisory Board |
David I. Scheer | 68 | 2003 | Co-Founder & Chairman of the Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है